Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation
Abstract
The E6-AP ubiquitin ligase (human/mouse gene UBE3A/Ube3a) promotes the degradation of p53 in association with papilloma E6 protein, and maternal deficiency causes human Angelman syndrome (AS). Ube3a is imprinted with silencing of the paternal allele in hippocampus and cerebellum in mice. We found that the phenotype of mice with maternal deficiency (m-/p+) for Ube3a resembles human AS with motor dysfunction, inducible seizures, and a context-dependent learning deficit. Long-term potentiation (LTP) was severely impaired in m-/p+ mice despite normal baseline synaptic transmission and neuroanatomy, indicating that ubiquitination may play a role in mammalian LTP and that LTP may be abnormal in AS. The cytoplasmic abundance of p53 was increased in postmitotic neurons in m-/p+ mice and in AS, providing a potential biochemical basis for the phenotype through failure to ubiquitinate and degrade various effectors.
References
Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII during long-term potentiation
Citations
An unexpected function of the Prader-Willi syndrome imprinting center in maternal imprinting in mice
Activity-dependent phosphorylation of GABAA receptors regulates receptor insertion and tonic current
Model mice for 15q11-13 duplication syndrome exhibit late-onset obesity and altered lipid metabolism
The ubiquitin proteasome system acutely regulates presynaptic protein turnover and synaptic efficacy
Bioinformatics analyses show dysregulation of calcium-related genes in Angelman syndrome mouse model
Related Concepts
Related Feeds
Brain developing: Influences & Outcomes
This feed focuses on influences that affect the developing brain including genetics, fetal development, prenatal care, and gene-environment interactions. Here is the latest research in this field.
Angelman Syndrome
Angelman syndrome is a neurogenetic imprinting disorder caused by loss of the maternally inherited UBE3A gene and is characterized by generalized epilepsy, limited expressive speech, sleep dysfunction, and movement disorders. Here is the latest research.